Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|July 1, 1995
Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancerM Fiegl, C Tueni, T Schenk, et al.
British Journal of Cancer|May 14, 1998
Chromosomal imbalances in primary and metastatic pancreatic carcinoma as detected by interphase cytogenetics: basic findings and clinical aspectsN Zojer, M Fiegl, L Müllauer, et al.
Blood|September 1, 1996
Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytesJ Drach, A Gsur, G Hamilton, et al.
Lung Cancer (Amsterdam, Netherlands)|July 22, 2014
Multicenter phase II study evaluating docetaxel and cisplatin as neoadjuvant induction regimen prior to surgery or radiochemotherapy with docetaxel, followed by adjuvant docetaxel therapy in chemonaive patients with NSCLC stage II, IIIA and IIIB (TAX-AT 1.203 Trial)F Kocher, A Pircher, A Mohn-Staudner, et al.
Blood|November 15, 1995
Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significanceJ Drach, J Angerler, J Schuster, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 3, 2014
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphomaM Mian, L Marcheselli, A Rossi, et al.
Blood|July 29, 1998
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapyJ Drach, J Ackermann, E Fritz, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2014
Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patientsM Fiegl, A Pircher, C Waldthaler, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2010
Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categoriesM Fiegl, M Erdel, I Tinhofer, et al.
Oncogene|March 30, 2004
Cyclin E dysregulation and chromosomal instability in endometrial cancerMichael M Hubalek, Andreas Widschwendter, Martin Erdel, et al.
Pageof 5